- Home
- SMID vs HRTX Comparison
SMID vs HRTX Comparison
Compare SMID & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- HRTX
- Stock Information
- Founded
- SMID 1960
- HRTX 1983
- Country
- SMID United States
- HRTX United States
- Employees
- SMID N/A
- HRTX N/A
- Industry
- SMID Building Materials
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- SMID Industrials
- HRTX Health Care
- Exchange
- SMID Nasdaq
- HRTX Nasdaq
- Market Cap
- SMID 206.7M
- HRTX 242.0M
- IPO Year
- SMID 1995
- HRTX 1987
- Fundamental
- Price
- SMID $36.14
- HRTX $1.32
- Analyst Decision
- SMID
- HRTX Strong Buy
- Analyst Count
- SMID 0
- HRTX 2
- Target Price
- SMID N/A
- HRTX $4.50
- AVG Volume (30 Days)
- SMID 11.0K
- HRTX 1.7M
- Earning Date
- SMID 08-14-2025
- HRTX 11-11-2025
- Dividend Yield
- SMID N/A
- HRTX N/A
- EPS Growth
- SMID 162.25
- HRTX N/A
- EPS
- SMID 2.27
- HRTX N/A
- Revenue
- SMID $90,998,000.00
- HRTX $149,694,000.00
- Revenue This Year
- SMID N/A
- HRTX $10.62
- Revenue Next Year
- SMID N/A
- HRTX $12.99
- P/E Ratio
- SMID $15.90
- HRTX N/A
- Revenue Growth
- SMID 32.97
- HRTX 9.78
- 52 Week Low
- SMID $25.13
- HRTX $1.04
- 52 Week High
- SMID $51.96
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- SMID 41.00
- HRTX 51.15
- Support Level
- SMID $35.16
- HRTX $1.23
- Resistance Level
- SMID $37.25
- HRTX $1.31
- Average True Range (ATR)
- SMID 2.33
- HRTX 0.06
- MACD
- SMID -0.33
- HRTX 0.02
- Stochastic Oscillator
- SMID 24.92
- HRTX 73.68
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.